{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:07:20Z","timestamp":1790356040181,"version":"4.1.0"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:00:00Z","timestamp":1528934400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:00:00Z","timestamp":1528934400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG5131"],"award-info":[{"award-number":["AG5131"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG018440"],"award-info":[{"award-number":["AG018440"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG051839"],"award-info":[{"award-number":["AG051839"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s00401-018-1869-0","type":"journal-article","created":{"date-parts":[[2018,6,13]],"date-time":"2018-06-13T23:47:31Z","timestamp":1528933651000},"page":"69-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Selective targeting of 3 repeat Tau with brain penetrating single chain antibodies for the treatment of neurodegenerative disorders"],"prefix":"10.1007","volume":"136","author":[{"given":"Brian","family":"Spencer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Br\u00fcschweiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Sealey-Cardona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Rockenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Adame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jazmin","family":"Florio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivy","family":"Trinh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Rissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Konrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliezer","family":"Masliah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,14]]},"reference":[{"key":"1869_CR1","doi-asserted-by":"publisher","first-page":"e10810","DOI":"10.1371\/journal.pone.0010810","volume":"5","author":"SJ Adams","year":"2010","unstructured":"Adams SJ, DeTure MA, McBride M, Dickson DW, Petrucelli L (2010) Three repeat isoforms of tau inhibit assembly of four repeat tau filaments. PLoS One 5:e10810. https:\/\/doi.org\/10.1371\/journal.pone.0010810","journal-title":"PLoS One"},{"key":"1869_CR2","doi-asserted-by":"publisher","first-page":"980250","DOI":"10.1155\/2012\/980250","volume":"2012","author":"ZA Ahmad","year":"2012","unstructured":"Ahmad ZA, Yeap SK, Ali AM, Ho WY, Alitheen NB, Hamid M (2012) scFv antibody: principles and clinical application. Clin Dev Immunol 2012:980250. https:\/\/doi.org\/10.1155\/2012\/980250","journal-title":"Clin Dev Immunol"},{"key":"1869_CR3","unstructured":"Alzheimer\u2019s\u00a0Association (2015) Latest facts and figures report"},{"key":"1869_CR4","doi-asserted-by":"publisher","first-page":"10626","DOI":"10.1021\/bi00158a027","volume":"31","author":"A Andreadis","year":"1992","unstructured":"Andreadis A, Brown WM, Kosik KS (1992) Structure and novel exons of the human tau gene. Biochemistry 31:10626\u201310633","journal-title":"Biochemistry"},{"key":"1869_CR5","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.brainresbull.2016.08.018","volume":"126","author":"T Arendt","year":"2016","unstructured":"Arendt T, Stieler JT, Holzer M (2016) Tau and tauopathies. Brain Res Bull 126:238\u2013292. https:\/\/doi.org\/10.1016\/j.brainresbull.2016.08.018","journal-title":"Brain Res Bull"},{"key":"1869_CR6","doi-asserted-by":"publisher","first-page":"9115","DOI":"10.1523\/JNEUROSCI.2361-07.2007","volume":"27","author":"AA Asuni","year":"2007","unstructured":"Asuni AA, Boutajangout A, Quartermain D, Sigurdsson EM (2007) Immunotherapy targeting pathological tau conformers in a tangle mouse model reduces brain pathology with associated functional improvements. J Neurosci 27:9115\u20139129. https:\/\/doi.org\/10.1523\/JNEUROSCI.2361-07.2007","journal-title":"J Neurosci"},{"key":"1869_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/nrn2194","volume":"8","author":"C Ballatore","year":"2007","unstructured":"Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders. Nat Rev Neurosci 8:663\u2013672. https:\/\/doi.org\/10.1038\/nrn2194","journal-title":"Nat Rev Neurosci"},{"key":"1869_CR8","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1002\/bit.24795","volume":"110","author":"RJ Boado","year":"2013","unstructured":"Boado RJ, Lu JZ, Hui EK, Sumbria RK, Pardridge WM (2013) Pharmacokinetics and brain uptake in the rhesus monkey of a fusion protein of arylsulfatase a and a monoclonal antibody against the human insulin receptor. Biotechnol Bioeng 110:1456\u20131465. https:\/\/doi.org\/10.1002\/bit.24795","journal-title":"Biotechnol Bioeng"},{"key":"1869_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1111\/j.1471-4159.2011.07337.x","volume":"118","author":"A Boutajangout","year":"2011","unstructured":"Boutajangout A, Ingadottir J, Davies P, Sigurdsson EM (2011) Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain. J Neurochem 118:658\u2013667. https:\/\/doi.org\/10.1111\/j.1471-4159.2011.07337.x","journal-title":"J Neurochem"},{"key":"1869_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jnc.14207","volume":"143","author":"AK Braczynski","year":"2017","unstructured":"Braczynski AK, Schulz JB, Bach JP (2017) Vaccination strategies in tauopathies and synucleinopathies. J Neurochem 143:467\u2013488. https:\/\/doi.org\/10.1111\/jnc.14207","journal-title":"J Neurochem"},{"key":"1869_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2014.09.007","volume":"36","author":"J Bright","year":"2015","unstructured":"Bright J, Hussain S, Dang V, Wright S, Cooper B, Byun T, Ramos C, Singh A, Parry G, Stagliano N et al (2015) Human secreted tau increases amyloid-beta production. Neurobiol Aging 36:693\u2013709. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.09.007","journal-title":"Neurobiol Aging"},{"key":"1869_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13024-015-0025-8","volume":"10","author":"ML Caillet-Boudin","year":"2015","unstructured":"Caillet-Boudin ML, Buee L, Sergeant N, Lefebvre B (2015) Regulation of human MAPT gene expression. Molecular Neurodegener 10:28. https:\/\/doi.org\/10.1186\/s13024-015-0025-8","journal-title":"Molecular Neurodegener"},{"key":"1869_CR13","doi-asserted-by":"publisher","first-page":"7061","DOI":"10.1523\/JNEUROSCI.18-18-07061.1998","volume":"18","author":"N Canu","year":"1998","unstructured":"Canu N, Dus L, Barbato C, Ciotti MT, Brancolini C, Rinaldi AM, Novak M, Cattaneo A, Bradbury A, Calissano P (1998) Tau cleavage and dephosphorylation in cerebellar granule neurons undergoing apoptosis. J Neurosci 18:7061\u20137074","journal-title":"J Neurosci"},{"key":"1869_CR14","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1093\/brain\/awu213","volume":"137","author":"L Collin","year":"2014","unstructured":"Collin L, Bohrmann B, Gopfert U, Oroszlan-Szovik K, Ozmen L, Gruninger F (2014) Neuronal uptake of tau\/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer\u2019s disease. Brain 137:2834\u20132846. https:\/\/doi.org\/10.1093\/brain\/awu213","journal-title":"Brain"},{"key":"1869_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13024-016-0126-z","volume":"11","author":"EE Congdon","year":"2016","unstructured":"Congdon EE, Lin Y, Rajamohamedsait HB, Shamir DB, Krishnaswamy S, Rajamohamedsait WJ, Rasool S, Gonzalez V, Levenga J, Gu J et al (2016) Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy. Mol Neurodegener 11:62. https:\/\/doi.org\/10.1186\/s13024-016-0126-z","journal-title":"Mol Neurodegener"},{"key":"1869_CR16","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.neuroscience.2010.04.037","volume":"169","author":"HN Dawson","year":"2010","unstructured":"Dawson HN, Cantillana V, Jansen M, Wang H, Vitek MP, Wilcock DM, Lynch JR, Laskowitz DT (2010) Loss of tau elicits axonal degeneration in a mouse model of Alzheimer\u2019s disease. Neuroscience 169:516\u2013531. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.04.037","journal-title":"Neuroscience"},{"key":"1869_CR17","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1242\/jcs.114.6.1179","volume":"114","author":"HN Dawson","year":"2001","unstructured":"Dawson HN, Ferreira A, Eyster MV, Ghoshal N, Binder LI, Vitek MP (2001) Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J Cell Sci 114:1179\u20131187","journal-title":"J Cell Sci"},{"key":"1869_CR18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E (2016) The Cellular Phase of Alzheimer\u2019s Disease. Cell 164:603\u2013615. https:\/\/doi.org\/10.1016\/j.cell.2015.12.056","journal-title":"Cell"},{"key":"1869_CR19","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/JAD-2005-8301","volume":"8","author":"CA del Alonso","year":"2005","unstructured":"del Alonso CA, Iqbal K (2005) Tau-induced neurodegeneration: a clue to its mechanism. J Alzheimers Dis 8:223\u2013226","journal-title":"J Alzheimers Dis"},{"key":"1869_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/BF00197809","volume":"6","author":"F Delaglio","year":"1995","unstructured":"Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR 6:277\u2013293","journal-title":"J Biomol NMR"},{"key":"1869_CR21","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1007\/s12031-011-9589-0","volume":"45","author":"DW Dickson","year":"2011","unstructured":"Dickson DW, Kouri N, Murray ME, Josephs KA (2011) Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau). J Mol Neurosci 45:384\u2013389. https:\/\/doi.org\/10.1007\/s12031-011-9589-0","journal-title":"J Mol Neurosci"},{"key":"1869_CR22","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1126\/science.1152993","volume":"319","author":"R Dixit","year":"2008","unstructured":"Dixit R, Ross JL, Goldman YE, Holzbaur EL (2008) Differential regulation of dynein and kinesin motor proteins by tau. Science 319:1086\u20131089. https:\/\/doi.org\/10.1126\/science.1152993","journal-title":"Science"},{"key":"1869_CR23","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1146\/annurev-biophys-051013-022746","volume":"43","author":"SE Encalada","year":"2014","unstructured":"Encalada SE, Goldstein LS (2014) Biophysical challenges to axonal transport: motor-cargo deficiencies and neurodegeneration. Annu Rev Biophys 43:141\u2013169. https:\/\/doi.org\/10.1146\/annurev-biophys-051013-022746","journal-title":"Annu Rev Biophys"},{"key":"1869_CR24","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/NEN.0000000000000030","volume":"73","author":"I Ferrer","year":"2014","unstructured":"Ferrer I, Lopez-Gonzalez I, Carmona M, Arregui L, Dalfo E, Torrejon-Escribano B, Diehl R, Kovacs GG (2014) Glial and neuronal tau pathology in tauopathies: characterization of disease-specific phenotypes and tau pathology progression. J Neuropathol Exp Neurol 73:81\u201397. https:\/\/doi.org\/10.1097\/NEN.0000000000000030","journal-title":"J Neuropathol Exp Neurol"},{"key":"1869_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1093\/brain\/awx328","volume":"141","author":"SL Forrest","year":"2018","unstructured":"Forrest SL, Kril JJ, Stevens CH, Kwok JB, Hallupp M, Kim WS, Huang Y, McGinley CV, Werka H, Kiernan MC et al (2018) Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies. Brain 141:521\u2013534. https:\/\/doi.org\/10.1093\/brain\/awx328","journal-title":"Brain"},{"key":"1869_CR26","doi-asserted-by":"publisher","first-page":"10032","DOI":"10.1073\/pnas.1630428100","volume":"100","author":"TC Gamblin","year":"2003","unstructured":"Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N et al (2003) Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer\u2019s disease. Proc Natl Acad Sci U S A 100:10032\u201310037. https:\/\/doi.org\/10.1073\/pnas.1630428100","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1869_CR27","doi-asserted-by":"publisher","DOI":"10.2174\/1567205014666170417111859","author":"Y Gao","year":"2017","unstructured":"Gao Y, Tan L, Yu JT, Tan L (2017) Tau in Alzheimer\u2019s disease: mechanisms and therapeutic strategies. Curr Alzheimer Res. https:\/\/doi.org\/10.2174\/1567205014666170417111859","journal-title":"Curr Alzheimer Res"},{"key":"1869_CR28","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1002\/j.1460-2075.1990.tb07870.x","volume":"9","author":"M Goedert","year":"1990","unstructured":"Goedert M, Jakes R (1990) Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization. EMBO J 9:4225\u20134230","journal-title":"EMBO J"},{"key":"1869_CR29","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/0896-6273(89)90210-9","volume":"3","author":"M Goedert","year":"1989","unstructured":"Goedert M, Spillantini MG, Jakes R, Rutherford D, Crowther RA (1989) Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer\u2019s disease. Neuron 3:519\u2013526","journal-title":"Neuron"},{"key":"1869_CR30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s00401-017-1707-9","volume":"133","author":"T Guo","year":"2017","unstructured":"Guo T, Noble W, Hanger DP (2017) Roles of tau protein in health and disease. Acta Neuropathol 133:665\u2013704. https:\/\/doi.org\/10.1007\/s00401-017-1707-9","journal-title":"Acta Neuropathol"},{"key":"1869_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrm2101","volume":"8","author":"C Haass","year":"2007","unstructured":"Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer\u2019s amyloid beta-peptide. Nat Rev Mol Cell Biol 8:101\u2013112. https:\/\/doi.org\/10.1038\/nrm2101","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1869_CR32","doi-asserted-by":"publisher","first-page":"e2880","DOI":"10.1038\/cddis.2017.279","volume":"8","author":"A Habib","year":"2017","unstructured":"Habib A, Sawmiller D, Li S, Xiang Y, Rongo D, Tian J, Hou H, Zeng J, Smith A, Fan S et al (2017) LISPRO mitigates beta-amyloid and associated pathologies in Alzheimer\u2019s mice. Cell Death Dis 8:e2880. https:\/\/doi.org\/10.1038\/cddis.2017.279","journal-title":"Cell Death Dis"},{"key":"1869_CR33","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/369488a0","volume":"369","author":"A Harada","year":"1994","unstructured":"Harada A, Oguchi K, Okabe S, Kuno J, Terada S, Ohshima T, Sato-Yoshitake R, Takei Y, Noda T, Hirokawa N (1994) Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369:488\u2013491. https:\/\/doi.org\/10.1038\/369488a0","journal-title":"Nature"},{"key":"1869_CR34","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0896-6273(02)00789-4","volume":"35","author":"M Higuchi","year":"2002","unstructured":"Higuchi M, Ishihara T, Zhang B, Hong M, Andreadis A, Trojanowski J, Lee VM (2002) Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration. Neuron 35:433\u2013446","journal-title":"Neuron"},{"key":"1869_CR35","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1126\/science.282.5395.1914","volume":"282","author":"M Hong","year":"1998","unstructured":"Hong M, Zhukareva V, Vogelsberg-Ragaglia V, Wszolek Z, Reed L, Miller BI, Geschwind DH, Bird TD, McKeel D, Goate A et al (1998) Mutation-specific functional impairments in distinct tau isoforms of hereditary FTDP-17. Science 282:1914\u20131917","journal-title":"Science"},{"key":"1869_CR36","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1038\/31508","volume":"393","author":"M Hutton","year":"1998","unstructured":"Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, Pickering-Brown S, Chakraverty S, Isaacs A, Grover A et al (1998) Association of missense and 5\u2032-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702\u2013705. https:\/\/doi.org\/10.1038\/31508","journal-title":"Nature"},{"key":"1869_CR37","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/S0304-3940(99)00964-7","volume":"279","author":"S Ikegami","year":"2000","unstructured":"Ikegami S, Harada A, Hirokawa N (2000) Muscle weakness, hyperactivity, and impairment in fear conditioning in tau-deficient mice. Neurosci Lett 279:129\u2013132","journal-title":"Neurosci Lett"},{"key":"1869_CR38","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1084\/jem.20162125","volume":"214","author":"C Ising","year":"2017","unstructured":"Ising C, Gallardo G, Leyns CEG, Wong CH, Stewart F, Koscal LJ, Roh J, Robinson GO, Remolina Serrano J, Holtzman DM (2017) AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy. J Exp Med 214:1227\u20131238. https:\/\/doi.org\/10.1084\/jem.20162125","journal-title":"J Exp Med"},{"key":"1869_CR39","doi-asserted-by":"publisher","first-page":"6246","DOI":"10.4049\/jimmunol.154.12.6246","volume":"154","author":"EJ Israel","year":"1995","unstructured":"Israel EJ, Patel VK, Taylor SF, Marshak-Rothstein A, Simister NE (1995) Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. J Immunol 154:6246\u20136251","journal-title":"J Immunol"},{"key":"1869_CR40","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1365-2567.1997.00326.x","volume":"92","author":"EJ Israel","year":"1997","unstructured":"Israel EJ, Taylor S, Wu Z, Mizoguchi E, Blumberg RS, Bhan A, Simister NE (1997) Expression of the neonatal Fc receptor, FcRn, on human intestinal epithelial cells. Immunology 92:69\u201374","journal-title":"Immunology"},{"key":"1869_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1111\/jnc.12821","volume":"132","author":"A Ittner","year":"2015","unstructured":"Ittner A, Bertz J, Suh LS, Stevens CH, Gotz J, Ittner LM (2015) Tau-targeting passive immunization modulates aspects of pathology in tau transgenic mice. J Neurochem 132:135\u2013145. https:\/\/doi.org\/10.1111\/jnc.12821","journal-title":"J Neurochem"},{"key":"1869_CR42","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1002\/(SICI)1097-4547(19970415)48:2<128::AID-JNR5>3.0.CO;2-E","volume":"48","author":"GA Jicha","year":"1997","unstructured":"Jicha GA, Bowser R, Kazam IG, Davies P (1997) Alz-50 and MC-1, a new monoclonal antibody raised to paired helical filaments, recognize conformational epitopes on recombinant tau. J Neurosci Res 48:128\u2013132","journal-title":"J Neurosci Res"},{"key":"1869_CR43","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/323346a0","volume":"323","author":"NH Jones","year":"1986","unstructured":"Jones NH, Clabby ML, Dialynas DP, Huang HJ, Herzenberg LA, Strominger JL (1986) Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1\/Leu-1. Nature 323:346\u2013349","journal-title":"Nature"},{"issue":"826","key":"1869_CR44","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1016\/j.neurobiolaging.2011.06.006","volume":"33","author":"NM Kanaan","year":"2012","unstructured":"Kanaan NM, Morfini G, Pigino G, LaPointe NE, Andreadis A, Song Y, Leitman E, Binder LI, Brady ST (2012) Phosphorylation in the amino terminus of tau prevents inhibition of anterograde axonal transport. Neurobiol Aging 33(826):e815\u2013e830. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2011.06.006","journal-title":"Neurobiol Aging"},{"key":"1869_CR45","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/alzrt278","volume":"6","author":"E Kontsekova","year":"2014","unstructured":"Kontsekova E, Zilka N, Kovacech B, Novak P, Novak M (2014) First-in-man tau vaccine targeting structural determinants essential for pathological tau-tau interaction reduces tau oligomerisation and neurofibrillary degeneration in an Alzheimer\u2019s disease model. Alzheimers Res Ther 6:44. https:\/\/doi.org\/10.1186\/alzrt278","journal-title":"Alzheimers Res Ther"},{"key":"1869_CR46","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/alzrt277","volume":"6","author":"E Kontsekova","year":"2014","unstructured":"Kontsekova E, Zilka N, Kovacech B, Skrabana R, Novak M (2014) Identification of structural determinants on tau protein essential for its pathological function: novel therapeutic target for tau immunotherapy in Alzheimer\u2019s disease. Alzheimers Res Ther 6:45. https:\/\/doi.org\/10.1186\/alzrt277","journal-title":"Alzheimers Res Ther"},{"key":"1869_CR47","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/0896-6273(89)90077-9","volume":"2","author":"KS Kosik","year":"1989","unstructured":"Kosik KS, Orecchio LD, Bakalis S, Neve RL (1989) Developmentally regulated expression of specific tau sequences. Neuron 2:1389\u20131397","journal-title":"Neuron"},{"key":"1869_CR48","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/nan.12208","volume":"41","author":"GG Kovacs","year":"2015","unstructured":"Kovacs GG (2015) Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol 41:3\u201323. https:\/\/doi.org\/10.1111\/nan.12208","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1869_CR49","doi-asserted-by":"publisher","first-page":"16835","DOI":"10.1523\/JNEUROSCI.2755-14.2014","volume":"34","author":"S Krishnaswamy","year":"2014","unstructured":"Krishnaswamy S, Lin Y, Rajamohamedsait WJ, Rajamohamedsait HB, Krishnamurthy P, Sigurdsson EM (2014) Antibody-derived in vivo imaging of tau pathology. J Neurosci 34:16835\u201316850. https:\/\/doi.org\/10.1523\/JNEUROSCI.2755-14.2014","journal-title":"J Neurosci"},{"key":"1869_CR50","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1523\/JNEUROSCI.2305-16.2017","volume":"37","author":"V Lacovich","year":"2017","unstructured":"Lacovich V, Espindola SL, Alloatti M, Pozo Devoto V, Cromberg LE, Carna ME, Forte G, Gallo JM, Bruno L, Stokin GB et al (2017) Tau isoforms imbalance impairs the axonal transport of the amyloid precursor protein in human neurons. J Neurosci 37:58\u201369. https:\/\/doi.org\/10.1523\/JNEUROSCI.2305-16.2017","journal-title":"J Neurosci"},{"key":"1869_CR51","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1146\/annurev.neuro.24.1.1121","volume":"24","author":"VM Lee","year":"2001","unstructured":"Lee VM, Goedert M, Trojanowski JQ (2001) Neurodegenerative tauopathies. Annu Rev Neurosci 24:1121\u20131159. https:\/\/doi.org\/10.1146\/annurev.neuro.24.1.1121","journal-title":"Annu Rev Neurosci"},{"key":"1869_CR52","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/nrd.2017.155","volume":"16","author":"C Li","year":"2017","unstructured":"Li C, Gotz J (2017) Tau-based therapies in neurodegeneration: opportunities and challenges. Nat Rev Drug Discov 16:863\u2013883. https:\/\/doi.org\/10.1038\/nrd.2017.155","journal-title":"Nat Rev Drug Discov"},{"key":"1869_CR53","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1073\/pnas.92.22.10369","volume":"92","author":"P LoPresti","year":"1995","unstructured":"LoPresti P, Szuchet S, Papasozomenos SC, Zinkowski RP, Binder LI (1995) Functional implications for the microtubule-associated protein tau: localization in oligodendrocytes. Proc Natl Acad Sci U S A 92:10369\u201310373","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1869_CR54","doi-asserted-by":"publisher","first-page":"e19338","DOI":"10.1371\/journal.pone.0019338","volume":"6","author":"E Masliah","year":"2011","unstructured":"Masliah E, Rockenstein E, Mante M, Crews L, Spencer B, Adame A, Patrick C, Trejo M, Ubhi K, Rohn TT et al (2011) Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. PLoS One 6:e19338. https:\/\/doi.org\/10.1371\/journal.pone.0019338","journal-title":"PLoS One"},{"key":"1869_CR55","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1126\/science.287.5456.1265","volume":"287","author":"E Masliah","year":"2000","unstructured":"Masliah E, Rockenstein E, Veinbergs I, Mallory M, Hashimoto M, Takeda A, Sagara Y, Sisk A, Mucke L (2000) Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders. Science 287:1265\u20131269","journal-title":"Science"},{"key":"1869_CR56","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/978-1-4939-2806-4_21","volume":"1324","author":"E Masliah","year":"2015","unstructured":"Masliah E, Spencer B (2015) Applications of ApoB LDLR-binding domain approach for the development of CNS-penetrating peptides for Alzheimer\u2019s disease. Methods Mol Biol 1324:331\u2013337. https:\/\/doi.org\/10.1007\/978-1-4939-2806-4_21","journal-title":"Methods Mol Biol"},{"key":"1869_CR57","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/nm.3951","volume":"21","author":"SW Min","year":"2015","unstructured":"Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA et al (2015) Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits. Nat Med 21:1154\u20131162. https:\/\/doi.org\/10.1038\/nm.3951","journal-title":"Nat Med"},{"key":"1869_CR58","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","volume":"2","author":"L Mucke","year":"2012","unstructured":"Mucke L, Selkoe DJ (2012) Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harbor Perspect Med 2:a006338. https:\/\/doi.org\/10.1101\/cshperspect.a006338","journal-title":"Cold Spring Harbor Perspect Med"},{"key":"1869_CR59","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s004410050809","volume":"288","author":"R Muller","year":"1997","unstructured":"Muller R, Heinrich M, Heck S, Blohm D, Richter-Landsberg C (1997) Expression of microtubule-associated proteins MAP2 and tau in cultured rat brain oligodendrocytes. Cell Tissue Res 288:239\u2013249","journal-title":"Cell Tissue Res"},{"key":"1869_CR60","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/brain\/awx052","volume":"140","author":"RM Nisbet","year":"2017","unstructured":"Nisbet RM, Van der Jeugd A, Leinenga G, Evans HT, Janowicz PW, Gotz J (2017) Combined effects of scanning ultrasound and a tau-specific single chain antibody in a tau transgenic mouse model. Brain 140:1220\u20131230. https:\/\/doi.org\/10.1093\/brain\/awx052","journal-title":"Brain"},{"key":"1869_CR61","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ncl.2017.01.008","volume":"35","author":"NT Olney","year":"2017","unstructured":"Olney NT, Spina S, Miller BL (2017) Frontotemporal dementia. Neurol Clin 35:339\u2013374. https:\/\/doi.org\/10.1016\/j.ncl.2017.01.008","journal-title":"Neurol Clin"},{"key":"1869_CR62","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1002\/jnr.490390607","volume":"39","author":"L Otvos Jr","year":"1994","unstructured":"Otvos L Jr, Feiner L, Lang E, Szendrei GI, Goedert M, Lee VM (1994) Monoclonal antibody PHF-1 recognizes tau protein phosphorylated at serine residues 396 and 404. J Neurosci Res 39:669\u2013673. https:\/\/doi.org\/10.1002\/jnr.490390607","journal-title":"J Neurosci Res"},{"key":"1869_CR63","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.bcp.2014.01.015","volume":"88","author":"CR Overk","year":"2014","unstructured":"Overk CR, Masliah E (2014) Pathogenesis of synaptic degeneration in Alzheimer\u2019s disease and Lewy body disease. Biochem Pharmacol 88:508\u2013516. https:\/\/doi.org\/10.1016\/j.bcp.2014.01.015","journal-title":"Biochem Pharmacol"},{"key":"1869_CR64","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.neuropharm.2011.04.025","volume":"62","author":"F Papaleo","year":"2012","unstructured":"Papaleo F, Lipska BK, Weinberger DR (2012) Mouse models of genetic effects on cognition: relevance to schizophrenia. Neuropharmacology 62:1204\u20131220. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.04.025","journal-title":"Neuropharmacology"},{"key":"1869_CR65","doi-asserted-by":"publisher","first-page":"5365","DOI":"10.1523\/JNEUROSCI.1125-05.2005","volume":"25","author":"SY Park","year":"2005","unstructured":"Park SY, Ferreira A (2005) The generation of a 17\u00a0kDa neurotoxic fragment: an alternative mechanism by which tau mediates beta-amyloid-induced neurodegeneration. J Neurosci 25:5365\u20135375. https:\/\/doi.org\/10.1523\/JNEUROSCI.1125-05.2005","journal-title":"J Neurosci"},{"key":"1869_CR66","doi-asserted-by":"publisher","first-page":"23063","DOI":"10.1074\/jbc.M111.237974","volume":"286","author":"KR Patterson","year":"2011","unstructured":"Patterson KR, Remmers C, Fu Y, Brooker S, Kanaan NM, Vana L, Ward S, Reyes JF, Philibert K, Glucksman MJ et al (2011) Characterization of prefibrillar Tau oligomers in vitro and in Alzheimer disease. J Biol Chem 286:23063\u201323076. https:\/\/doi.org\/10.1074\/jbc.M111.237974","journal-title":"J Biol Chem"},{"key":"1869_CR67","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.molmed.2015.03.003","volume":"21","author":"JT Pedersen","year":"2015","unstructured":"Pedersen JT, Sigurdsson EM (2015) Tau immunotherapy for Alzheimer\u2019s disease. Trends Mol Med 21:394\u2013402. https:\/\/doi.org\/10.1016\/j.molmed.2015.03.003","journal-title":"Trends Mol Med"},{"key":"1869_CR68","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1172\/JCI20640","volume":"114","author":"RA Rissman","year":"2004","unstructured":"Rissman RA, Poon WW, Blurton-Jones M, Oddo S, Torp R, Vitek MP, LaFerla FM, Rohn TT, Cotman CW (2004) Caspase-cleavage of tau is an early event in Alzheimer disease tangle pathology. J Clin Invest 114:121\u2013130. https:\/\/doi.org\/10.1172\/JCI20640","journal-title":"J Clin Invest"},{"key":"1869_CR69","doi-asserted-by":"publisher","first-page":"e0121570","DOI":"10.1371\/journal.pone.0121570","volume":"10","author":"E Rockenstein","year":"2015","unstructured":"Rockenstein E, Overk CR, Ubhi K, Mante M, Patrick C, Adame A, Bisquert A, Trejo-Morales M, Spencer B, Masliah E (2015) A novel triple repeat mutant tau transgenic model that mimics aspects of pick\u2019s disease and fronto-temporal tauopathies. PLoS One 10:e0121570. https:\/\/doi.org\/10.1371\/journal.pone.0121570","journal-title":"PLoS One"},{"key":"1869_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-1-59745-450-6_3","volume":"524","author":"O Rosen","year":"2009","unstructured":"Rosen O, Anglister J (2009) Epitope mapping of antibody-antigen complexes by nuclear magnetic resonance spectroscopy. Methods Mol Biol 524:37\u201357. https:\/\/doi.org\/10.1007\/978-1-59745-450-6_3","journal-title":"Methods Mol Biol"},{"key":"1869_CR71","doi-asserted-by":"publisher","first-page":"3842","DOI":"10.1074\/jbc.M111.277061","volume":"287","author":"S Saman","year":"2012","unstructured":"Saman S, Kim W, Raya M, Visnick Y, Miro S, Saman S, Jackson B, McKee AC, Alvarez VE, Lee NC et al (2012) Exosome-associated tau is secreted in tauopathy models and is selectively phosphorylated in cerebrospinal fluid in early Alzheimer disease. J Biol Chem 287:3842\u20133849. https:\/\/doi.org\/10.1074\/jbc.M111.277061","journal-title":"J Biol Chem"},{"key":"1869_CR72","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1046\/j.1471-4159.2002.00840.x","volume":"81","author":"F Schlachetzki","year":"2002","unstructured":"Schlachetzki F, Zhu C, Pardridge WM (2002) Expression of the neonatal Fc receptor (FcRn) at the blood-brain barrier. J Neurochem 81:203\u2013206","journal-title":"J Neurochem"},{"key":"1869_CR73","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1002\/glia.22832","volume":"63","author":"V Seiberlich","year":"2015","unstructured":"Seiberlich V, Bauer NG, Schwarz L, Ffrench-Constant C, Goldbaum O, Richter-Landsberg C (2015) Downregulation of the microtubule associated protein tau impairs process outgrowth and myelin basic protein mRNA transport in oligodendrocytes. Glia 63:1621\u20131635. https:\/\/doi.org\/10.1002\/glia.22832","journal-title":"Glia"},{"key":"1869_CR74","doi-asserted-by":"publisher","first-page":"595","DOI":"10.15252\/emmm.201606210","volume":"8","author":"DJ Selkoe","year":"2016","unstructured":"Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer\u2019s disease at 25 years. EMBO molecular medicine 8:595\u2013608. https:\/\/doi.org\/10.15252\/emmm.201606210","journal-title":"EMBO molecular medicine"},{"key":"1869_CR75","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1203\/01.PDR.0000047663.81816.E3","volume":"53","author":"U Shah","year":"2003","unstructured":"Shah U, Dickinson BL, Blumberg RS, Simister NE, Lencer WI, Walker WA (2003) Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr Res 53:295\u2013301. https:\/\/doi.org\/10.1203\/01.PDR.0000047663.81816.E3","journal-title":"Pediatr Res"},{"key":"1869_CR76","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jalz.2016.04.003","volume":"12","author":"M Shi","year":"2016","unstructured":"Shi M, Kovac A, Korff A, Cook TJ, Ginghina C, Bullock KM, Yang L, Stewart T, Zheng D, Aro P et al (2016) CNS tau efflux via exosomes is likely increased in Parkinson\u2019s disease but not in Alzheimer\u2019s disease. Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc 12:1125\u20131131. https:\/\/doi.org\/10.1016\/j.jalz.2016.04.003","journal-title":"Alzheimer\u2019s Dement J Alzheimer\u2019s Assoc"},{"key":"1869_CR77","doi-asserted-by":"publisher","first-page":"44425","DOI":"10.1074\/jbc.M112.415935","volume":"287","author":"HH Shih","year":"2012","unstructured":"Shih HH, Tu C, Cao W, Klein A, Ramsey R, Fennell BJ, Lambert M, Ni Shuilleabhain D, Autin B, Kouranova E et al (2012) An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognition. J Biol Chem 287:44425\u201344434. https:\/\/doi.org\/10.1074\/jbc.M112.415935","journal-title":"J Biol Chem"},{"key":"1869_CR78","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/j.jalz.2014.04.011","volume":"10","author":"L Sibener","year":"2014","unstructured":"Sibener L, Zaganjor I, Snyder HM, Bain LJ, Egge R, Carrillo MC (2014) Alzheimer\u2019s disease prevalence, costs, and prevention for military personnel and veterans. Alzheimer\u2019s Dement ia 10:S105\u2013S110. https:\/\/doi.org\/10.1016\/j.jalz.2014.04.011","journal-title":"Alzheimer\u2019s Dement ia"},{"key":"1869_CR79","doi-asserted-by":"publisher","DOI":"10.3390\/biom6010006","author":"G Simic","year":"2016","unstructured":"Simic G, Babic Leko M, Wray S, Harrington C, Delalle I, Jovanov-Milosevic N, Bazadona D, Buee L, de Silva R, Di Giovanni G et al (2016) Tau protein hyperphosphorylation and aggregation in Alzheimer\u2019s disease and other tauopathies, and possible neuroprotective strategies. Biomolecules. https:\/\/doi.org\/10.3390\/biom6010006","journal-title":"Biomolecules"},{"key":"1869_CR80","doi-asserted-by":"publisher","first-page":"7971","DOI":"10.1523\/JNEUROSCI.0775-16.2016","volume":"36","author":"B Spencer","year":"2016","unstructured":"Spencer B, Desplats PA, Overk CR, Valera-Martin E, Rissman RA, Wu C, Mante M, Adame A, Florio J, Rockenstein E et al (2016) Reducing endogenous alpha-synuclein mitigates the degeneration of selective neuronal populations in an Alzheimer\u2019s disease transgenic mouse model. J Neurosci 36:7971\u20137984. https:\/\/doi.org\/10.1523\/JNEUROSCI.0775-16.2016","journal-title":"J Neurosci"},{"key":"1869_CR81","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1038\/mt.2014.129","volume":"22","author":"B Spencer","year":"2014","unstructured":"Spencer B, Emadi S, Desplats P, Eleuteri S, Michael S, Kosberg K, Shen J, Rockenstein E, Patrick C, Adame A et al (2014) ESCRT-mediated uptake and degradation of brain-targeted alpha-synuclein single chain antibody attenuates neuronal degeneration in vivo. Mol Ther 22:1753\u20131767. https:\/\/doi.org\/10.1038\/mt.2014.129","journal-title":"Mol Ther"},{"key":"1869_CR82","doi-asserted-by":"publisher","first-page":"e16575","DOI":"10.1371\/journal.pone.0016575","volume":"6","author":"B Spencer","year":"2011","unstructured":"Spencer B, Marr RA, Gindi R, Potkar R, Michael S, Adame A, Rockenstein E, Verma IM, Masliah E (2011) Peripheral delivery of a CNS targeted, metalo-protease reduces abeta toxicity in a mouse model of Alzheimer\u2019s disease. PLoS One 6:e16575. https:\/\/doi.org\/10.1371\/journal.pone.0016575","journal-title":"PLoS One"},{"key":"1869_CR83","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/mt.2012.66","volume":"21","author":"B Spencer","year":"2013","unstructured":"Spencer B, Michael S, Shen J, Kosberg K, Rockenstein E, Patrick C, Adame A, Masliah E (2013) Lentivirus mediated delivery of neurosin promotes clearance of wild-type alpha-synuclein and reduces the pathology in an alpha-synuclein model of LBD. Mol Ther 21:31\u201341. https:\/\/doi.org\/10.1038\/mt.2012.66","journal-title":"Mol Ther"},{"key":"1869_CR84","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1074\/jbc.M115.678185","volume":"291","author":"B Spencer","year":"2016","unstructured":"Spencer B, Potkar R, Metcalf J, Thrin I, Adame A, Rockenstein E, Masliah E (2016) Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) reduces neurodegeneration and increases neural precursor cell proliferation in a mouse model of Alzheimer disease. J Biol Chem 291:1905\u20131920. https:\/\/doi.org\/10.1074\/jbc.M115.678185","journal-title":"J Biol Chem"},{"key":"1869_CR85","doi-asserted-by":"publisher","first-page":"13578","DOI":"10.1523\/JNEUROSCI.4390-09.2009","volume":"29","author":"B Spencer","year":"2009","unstructured":"Spencer B, Potkar R, Trejo M, Rockenstein E, Patrick C, Gindi R, Adame A, Wyss-Coray T, Masliah E (2009) Beclin 1 gene transfer activates autophagy and ameliorates the neurodegenerative pathology in alpha-synuclein models of Parkinson\u2019s and Lewy body diseases. J Neurosci 29:13578\u201313588","journal-title":"J Neurosci"},{"key":"1869_CR86","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-015-0043-6","volume":"10","author":"B Spencer","year":"2015","unstructured":"Spencer B, Valera E, Rockenstein E, Trejo-Morales M, Adame A, Masliah E (2015) A brain-targeted, modified neurosin (kallikrein-6) reduces alpha-synuclein accumulation in a mouse model of multiple system atrophy. Mol Neurodegener 10:48. https:\/\/doi.org\/10.1186\/s13024-015-0043-6","journal-title":"Mol Neurodegener"},{"key":"1869_CR87","doi-asserted-by":"publisher","first-page":"17917","DOI":"10.1074\/jbc.M114.557439","volume":"289","author":"B Spencer","year":"2014","unstructured":"Spencer B, Verma I, Desplats P, Morvinski D, Rockenstein E, Adame A, Masliah E (2014) A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis. J Biol Chem 289:17917\u201317931. https:\/\/doi.org\/10.1074\/jbc.M114.557439","journal-title":"J Biol Chem"},{"key":"1869_CR88","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/acn3.321","volume":"3","author":"B Spencer","year":"2016","unstructured":"Spencer B, Williams S, Rockenstein E, Valera E, Wei X, Mante M, Florio J, Adame A, Masliah E, Sierks M (2016) a-synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease. Ann Clin Transl Neurol 3:588\u2013606","journal-title":"Ann Clin Transl Neurol"},{"key":"1869_CR89","doi-asserted-by":"publisher","first-page":"7594","DOI":"10.1073\/pnas.0702170104","volume":"104","author":"BJ Spencer","year":"2007","unstructured":"Spencer BJ, Verma IM (2007) Targeted delivery of proteins across the blood-brain barrier. Proc Natl Acad Sci U S A 104:7594\u20137599. https:\/\/doi.org\/10.1073\/pnas.0702170104","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1869_CR90","doi-asserted-by":"publisher","first-page":"7737","DOI":"10.1073\/pnas.95.13.7737","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini MG, Murrell JR, Goedert M, Farlow MR, Klug A, Ghetti B (1998) Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc Natl Acad Sci U S A 95:7737\u20137741","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1869_CR91","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1159\/000440840","volume":"16","author":"P Tacik","year":"2016","unstructured":"Tacik P, Sanchez-Contreras M, Rademakers R, Dickson DW, Wszolek ZK (2016) Genetic disorders with Tau pathology: a review of the literature and report of two patients with tauopathy and positive family histories. Neurodegener Dis 16:12\u201321. https:\/\/doi.org\/10.1159\/000440840","journal-title":"Neurodegener Dis"},{"key":"1869_CR92","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/978-1-4614-0653-2_23","volume":"724","author":"N Takeda","year":"2012","unstructured":"Takeda N, Kishimoto Y, Yokota O (2012) Pick\u2019s disease. Adv Exp Med Biol 724:300\u2013316. https:\/\/doi.org\/10.1007\/978-1-4614-0653-2_23","journal-title":"Adv Exp Med Biol"},{"key":"1869_CR93","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1038\/emboj.2009.389","volume":"29","author":"S Terada","year":"2010","unstructured":"Terada S, Kinjo M, Aihara M, Takei Y, Hirokawa N (2010) Kinesin-1\/Hsc70-dependent mechanism of slow axonal transport and its relation to fast axonal transport. EMBO J 29:843\u2013854. https:\/\/doi.org\/10.1038\/emboj.2009.389","journal-title":"EMBO J"},{"key":"1869_CR94","first-page":"179","volume-title":"Alzheimer disease","author":"R Terry","year":"1994","unstructured":"Terry R, Hansen L, Masliah E (1994) Structural basis of the cognitive alterations in Alzheimer disease. In: Terry R, Katzman R (eds) Alzheimer disease. Raven Press, New York City, pp 179\u2013196"},{"key":"1869_CR95","doi-asserted-by":"publisher","first-page":"e72301","DOI":"10.1371\/journal.pone.0072301","volume":"8","author":"C Theunis","year":"2013","unstructured":"Theunis C, Crespo-Biel N, Gafner V, Pihlgren M, Lopez-Deber MP, Reis P, Hickman DT, Adolfsson O, Chuard N, Ndao DM et al (2013) Efficacy and safety of a liposome-based vaccine against protein Tau, assessed in tau.P301L mice that model tauopathy. PLoS One 8:e72301. https:\/\/doi.org\/10.1371\/journal.pone.0072301","journal-title":"PLoS One"},{"key":"1869_CR96","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s13311-015-0397-z","volume":"13","author":"E Valera","year":"2016","unstructured":"Valera E, Spencer B, Masliah E (2016) Immunotherapeutic approaches targeting amyloid-beta, alpha-Synuclein, and Tau for the treatment of neurodegenerative disorders. Neurotherapeutics 13:179\u2013189. https:\/\/doi.org\/10.1007\/s13311-015-0397-z","journal-title":"Neurotherapeutics"},{"key":"1869_CR97","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/prot.20449","volume":"59","author":"WF Vranken","year":"2005","unstructured":"Vranken WF, Boucher W, Stevens TJ, Fogh RH, Pajon A, Llinas M, Ulrich EL, Markley JL, Ionides J, Laue ED (2005) The CCPN data model for NMR spectroscopy: development of a software pipeline. Proteins 59:687\u2013696. https:\/\/doi.org\/10.1002\/prot.20449","journal-title":"Proteins"},{"key":"1869_CR98","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/nrn.2015.1","volume":"17","author":"Y Wang","year":"2016","unstructured":"Wang Y, Mandelkow E (2016) Tau in physiology and pathology. Nat Rev Neurosci 17:5\u201321. https:\/\/doi.org\/10.1038\/nrn.2015.1","journal-title":"Nat Rev Neurosci"},{"key":"1869_CR99","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.dadm.2016.04.001","volume":"3","author":"CN Winston","year":"2016","unstructured":"Winston CN, Goetzl EJ, Akers JC, Carter BS, Rockenstein EM, Galasko D, Masliah E, Rissman RA (2016) Prediction of conversion from mild cognitive impairment to dementia with neuronally derived blood exosome protein profile. Alzheimers Dement (Amst) 3:63\u201372. https:\/\/doi.org\/10.1016\/j.dadm.2016.04.001","journal-title":"Alzheimers Dement (Amst)"},{"key":"1869_CR100","doi-asserted-by":"publisher","first-page":"E8187","DOI":"10.1073\/pnas.1616344113","volume":"113","author":"AL Woerman","year":"2016","unstructured":"Woerman AL, Aoyagi A, Patel S, Kazmi SA, Lobach I, Grinberg LT, McKee AC, Seeley WW, Olson SH, Prusiner SB (2016) Tau prions from Alzheimer\u2019s disease and chronic traumatic encephalopathy patients propagate in cultured cells. Proc Natl Acad Sci U S A 113:E8187\u2013E8196. https:\/\/doi.org\/10.1073\/pnas.1616344113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1869_CR101","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.neuron.2013.07.046","volume":"80","author":"K Yanamandra","year":"2013","unstructured":"Yanamandra K, Kfoury N, Jiang H, Mahan TE, Ma S, Maloney SE, Wozniak DF, Diamond MI, Holtzman DM (2013) Anti-tau antibodies that block tau aggregate seeding in vitro markedly decrease pathology and improve cognition in vivo. Neuron 80:402\u2013414. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.046","journal-title":"Neuron"},{"key":"1869_CR102","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00281-006-0054-z","volume":"28","author":"M Yoshida","year":"2006","unstructured":"Yoshida M, Masuda A, Kuo TT, Kobayashi K, Claypool SM, Takagawa T, Kutsumi H, Azuma T, Lencer WI, Blumberg RS (2006) IgG transport across mucosal barriers by neonatal Fc receptor for IgG and mucosal immunity. Springer Semin Immunopathol 28:397\u2013403. https:\/\/doi.org\/10.1007\/s00281-006-0054-z","journal-title":"Springer Semin Immunopathol"}],"updated-by":[{"DOI":"10.1007\/s00401-026-02982-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000}}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-018-1869-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-018-1869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-018-1869-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:57:44Z","timestamp":1771502264000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-018-1869-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,14]]},"references-count":102,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["1869"],"URL":"https:\/\/doi.org\/10.1007\/s00401-018-1869-0","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,14]]},"assertion":[{"value":"10 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to incorrect figures 6, 7 and 10 in the article. Now, the figures has been corrected.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":9,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":10,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00401-026-02982-y","URL":"https:\/\/doi.org\/10.1007\/s00401-026-02982-y","order":12,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}